Soluble HLA-G in Rheumatoid Arthritis

Human Immunology

Volumn 67, Issue 8, 2006, Pages 561-567

  Verbruggen, Leon A ^a   Rebmann, Vera ^b   Demanet, Christian ^a   De Cock, Seija ^a   Grosse Wilde, Hans ^b  

^a UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

HLA DQB1; HLA DRB1; rheumatoid arthritis; soluble HLA class I; Soluble HLA G

Indexed keywords

C REACTIVE PROTEIN; EPITOPE; HLA ANTIGEN CLASS 1; HLA DQB1 ANTIGEN; HLA DR ANTIGEN; HLA G ANTIGEN; RHEUMATOID FACTOR;

ADULT; ARTICLE; CELL ACTIVITY; CLINICAL ASSESSMENT; CLINICAL OBSERVATION; CONTROLLED STUDY; CORRELATION COEFFICIENT; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENOTYPE; HUMAN; JOINT SWELLING; LYMPHOCYTE FUNCTION; MALE; NATURAL KILLER CELL; PLASMA; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SCORING SYSTEM; SENSITIVITY ANALYSIS; SOLUBILITY; T LYMPHOCYTE;

ARTHRITIS, RHEUMATOID; EPITOPES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HLA-DQ ANTIGENS; HLA-DR ANTIGENS; HUMANS; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED;

EID: 33747013747     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2006.03.023     Document Type: Article

References (43)

1. LeMaoult J., Le Discorde M., Rouas-Freiss N., Moreau P., Menier C., McCluskey J., and Carosella E.D. Biology and functions of human leukocyte antigen-G in health and sickness. Tissue Antigens 62 (2003) 273
2. Carosella E.D., Moreau P., Aractingi S., and Rouas-Freiss N. HLA-G. a shield against inflammatory aggression. Trends Immunol 22 (2001) 553
3. Aractingi S., Kanitakis J., Euvrard S., Le Danff C., and Carosella E.D. Selective expression of HLA-G in malignant and premalignant skin specimens in kidney transplant recipients. Int J Cancer 106 (2003) 232
4. Torres M.I., Le Discorde M., Lorite P., Rios A., Gassull M.A., Gil A., Maldonado J., Dausset J., and Carosella E.D. Expression of HLA-G in inflammatory bowel disease provides a potential way to distinguish between ulcerative colitis and Crohn's disease. Int Immunol 16 (2004) 579
5. Rebmann V., Regel J., Stolke D., and Grosse-Wilde H. Secretion of sHLA-G molecules in malignancies. Semin Cancer Biol 13 (2003) 371
6. Rouas-Freiss N., Moreau P., Menier C., and Carosella E.D. HLA-G in cancer. a way to turn off the immune system. Semin Cancer Biol 13 (2003) 325
7. LeMaoult J., Krawice-Radanne I., Dausset J., and Carosella E.D. HLA-G1-expressing antigen-presenting cells induce immunosuppressive CD4+ T cells. Proc Natl Acad Sci 101 (2004) 7064
8. Carosella E.D., Rouas-Freiss N., Paul P., and Dausset J. HLA-G. a tolerance molecule from the major histocompatibility complex. Immunol Today 20 (1999) 60
9. Seliger B., Abken H., and Ferrone S. HLA-G and MIC expression in tumors and their role in anti-tumor immunity. Trends Immunol 24 (2003) 82
10. Urosevic M., and Dummer R. HLA-G in skin cancer. a wolf in sheep's clothing?. Hum Immunol 64 (2003) 1073
11. Nückel H., Rebmann V., Dürig J., Dührsen U., and Grosse-Wilde H. HLA-G expression is associated with an unfavorable outcome and immunodeficiency in chronic lymphocytic leukemia. Blood 105 (2005) 1694
12. Amiot L., Le Friec G., Sebti Y., Drénou B., Pangault C., Guilloux V., Leleu X., Bernard M., Facon T., and Fauchet R. HLA-G and lymphoproliferative disorders. Semin Cancer Biol 13 (2003) 379
13. Creput C., Le Friec G., Bahri R., Amiot L., Charpentier B., Carosella E., Rouas-Freiss N., and Durrbach A. Detection of HLA-G in serum and graft biopsy associated with fewer acute rejections following combined liver-kidney transplantation. possible implications for monitoring patients. Hum Immunol 64 (2003) 1033
14. Lila N., Rouas-Freiss N., Dausset J., Carpentier A., and Carosella E.D. Soluble HLA-G protein secreted by allo-specific CD4+ T cells suppresses the allo-proliferative response. a CD4+ T cell regulatory mechanism. Proc Natl Acad Sci USA 98 (2001) 12150
15. Wiendl H., Mitsdoerffer M., and Weller M. Express and protect yourself. the potential role of HLA-G on muscle cells and in inflammatory myopathies. Hum Immunol 64 (2003) 1050
16. Aractingi S., Briand N., Le Danff C., Viguier M., Bachelez H., Michel L., Dubertret L., and Carosella E.D. HLA-G and NK receptor are expressed in psoriatic skin. a possible pathway for regulating infiltrating T cells?. Am J Pathol 159 (2001) 71
17. Bresciani A., Pirozzi G., Spera M., Lombardi M.L., Ambrosone L., Migliarese S., Ferrone S., and Manzo C. Increased level of serum HLA class I antigens in patients with systemic lupus erythematosus. Correlation with disease activity. Tissue Antigens 52 (1998) 44
18. Kippner L., Klint C., Sturfelt G., Bengtsson A.A., Eriksson H., and Truedsson L. Increased level of soluble HLA class I antigens in systemic lupus erythematosus. correlation with anti-DNA antibodies and leukopenia. J Autoimmun 16 (2001) 471
19. Wolf R.E., Adamashvili I.M., Gelder F.B., Hall V.C., Fraser P.A., and McDonald J.C. Soluble HLA-I in rheumatic diseases. Hum Immunol 59 (1998) 644
20. Rebmann V., and Grosse-Wilde H. Detection of soluble HLA. In: Bidwell J.L., and Navarrete C. (Eds). Histocompatibility testing (2000), Imperial College Press, London
21. Munoz-Fernandez S., Martin J., Martin-Mola E., Garcia-Rodriguez M.C., Cantalejo M., Fontan G., and Ferreira A. Soluble HLA class I antigens in serum and synovial fluid from patients with rheumatoid arthritis and other arthropathies. Rheumatology 40 (2001) 1365
22. Weyand C.M., McCarthy T.G., and Goronzy J.J. Correlation between disease phenotype and genetic heterogeneity in rheumatoid arthritis. J Clin Invest 95 (1995) 2120
23. Rowley M.J., Stockman A., Brand C.A., Tait B.D., Rowley G.L., Sherritt M.A., Mackay I.R., Muirden K.D., and Bernard C.C.A. The effect of HLA-DRB1 disease susceptibility markers on the expression of RA. Scand J Rheumatol 26 (1997) 448
24. Seidl C., Koch U., Buhleier T., Möller B., Wigand R., Markert E., Koller-Wagner G., Seifried E., and Kaltwasser J.P. Association of (Q)R/KRAA positive HLA-DRB1 alleles with disease progression in early active and severe rheumatoid arthritis. J Rheumatol 26 (1999) 773
25. De Vries N., Tijssen H., Van Riel P.L.C.M., and Van de Putte L.B.A. Reshaping the shared epitope hypothesis. HLA-associated risk for rheumatoid arthritis is encoded by amino acid substitutions at positions 67-74 of the HLA-DRB1 molecule. Arthritis Rheum 46 (2002) 921
26. Verbruggen L.A., Dumarey N., Van de Velde H., Rebmann V., Flament J., Van Wayenberge C., Grosse-Wilde H., and Demanet C. Soluble HLA-DR antigen levels in serum correlate with rheumatoid arthritis disease activity and the presence of disease-associated epitopes. Tissue Antigens 56 (2000) 436
27. Arnett F.C., Edworthy S.M., Bloch D.A., McShane D.J., Fries J.F., Cooper N.S., Healey L.A., Kaplan S.R., Liang M.H., Luthra H.S., Medsger Jr. T.A., Mitchell D.M., Neustadt D.H., Pinals R.S., Schaller J.G., Sharp J.T., Wilder R.L., and Hunder G.G. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31 (1988) 315
28. Smolen J.S. Report on the EULAR standing committee on international clinical studies including therapeutic trials. Rheumatol Eur 23 (1994) 37
29. Rebmann V., Pfeiffer K., Päßler M., Ferrone S., Maier S., Weiss E., and Grosse-Wilde H. Detection of soluble HLA-G molecules in plasma and amniotic fluid. Tissue Antigens 53 (1999) 14
30. Rebmann V., Van der Ven K., Päßler M., Pfeiffer K., Krebs D., and Grosse-Wilde H. Association of soluble HLA-G plasma levels with HLA-G alleles. Tissue Antigens 57 (2001) 15
31. Yen J.H., Moore B.E., Nakajima T., Scholl D., Schaid D.J., Weyand C.M., and Goronzy J.J. Major Histocompatibility complex class I-recognizing receptors are disease risk genes in rheumatoid arthritis. J Exp Med 193 (2001) 1159
32. Smith J.B., and Haynes M.K. Rheumatoid arthritis-A molecular understanding. Ann Intern Med 136 (2002) 908
33. Hviid T.V.F., and Christiansen O.B. Linkage disequilibrium between human leukocyte antigen (HLA) class II and HLA-G-Possible implications for human reproduction and autoimmune disease. Hum Immunol 66 (2005) 688
34. Zanelli E., Breedveld F.C., and de Vries R.R.P. HLA class II association with RA. Human Immunol 61 (2000) 1254
35. Laivoranta-Nyman S., Möttönen T., Hermann R., Tuokko J., Luukkainen R., Hakala M., Hannonen P., Korpela M., Yli-Kerttula U., Toivanen A., Ilonen J., and FIN-RACo Trial Group. HLA-DR-DQ haplotypes and genotypes in Finnish patients with rheumatoid arthritis. Ann Rheum Dis 63 (2004) 1406
36. Milicic A., Lee D., Brown M.A., Darke C., and Wordsworth B.P. HLA-DR/DQ haplotype in rheumatoid arthritis. novel allelic associations in UK caucasians. J Rheumatol 29 (2002) 1821
37. Snijders A., Elferink D.G., Geluk A., van der Zanden A., Vos K., Schreuder G.M.T., Breedveld F.C., de Vries R.R.P., and Zanelli E.H. An HLA-DRB1-derived peptide associated with protection against rheumatoid arthritis is naturally processed by human APCs. J Immunol 166 (2001) 4987
38. Vos K., van der Horst-Bruinsma I.E., Hazes J.M.W., Breedveld F.C., le Cessie S., Schreuder G.M.T., de Vries R.R.P., and Zanelli E.H. Evidence for a protective role of the human leukocyte antigen class II region in early rheumatoid arthritis. Rheumatology 40 (2001) 133
39. Vos K., Visser H., Schreuder G.M.T., de Vries G.M.T., Zwinderman A.H., Breedveld F.C., Hazes J.M.W., and Zanelli E.H. Human leukocyte antigen-DQ and DR polymorphisms predict rheumatoid arthritis outcome better than DR alone. Human Immunol 62 (2001) 1217
40. Gibert M., Balandraud N., Touinssi M., Mercier P., Roudier J., and Reviron D. Functional categorization of HLA-DRB1 alleles in rheumatoid arthritis. the protective effect. Human Immunol 64 (2003) 930
41. Wagner U., Kaltenhauser S., Pierer M., Seidel W., Tröltzsch M., Hantzschel H., Kalden J.R., and Wassmuth R. Prospective analysis of the impact of HLA-DR and -DQ on joint destruction in recent-onset rheumatoid arthritis. Rheumatology 42 (2003) 553
42. Rizzo R., Hviid T.V.F., Stignani M., Balboni A., Grappa M.T., Melchiorri L., and Baricordi O.R. The HLA-G genotype is associated with IL-10 levels in activated PBMCs. Immunogenetics 57 (2005) 172
43. Singal D.P., Li J., and Zhu Y. HLA class III region and susceptibility to rheumatoid arthritis. Clin Exp Rheum 18 (2000) 485